Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 142

1.

Review article: drug hepatotoxicity.

Chang CY, Schiano TD.

Aliment Pharmacol Ther. 2007 May 15;25(10):1135-51. Review.

2.

Hepatotoxicity of thiazolidinediones.

Isley WL.

Expert Opin Drug Saf. 2003 Nov;2(6):581-6. Review.

PMID:
14585066
4.

Defining patient risks from expanded preventive therapies.

Tolman KG.

Am J Cardiol. 2000 Jun 22;85(12A):15E-9E. Review.

PMID:
10858489
5.

The rational use of potentially hepatotoxic medications in patients with underlying liver disease.

Lewis JH.

Expert Opin Drug Saf. 2002 Jul;1(2):159-72. Review.

PMID:
12904150
6.

[Hepatic tolerance of atypical antipsychotic drugs].

Dumortier G, Cabaret W, Stamatiadis L, Saba G, Benadhira R, Rocamora JF, Aubriot-Delmas B, Glikman J, Januel D.

Encephale. 2002 Nov-Dec;28(6 Pt 1):542-51. Review. French.

PMID:
12506267
7.

Drug-induced hepatotoxicity: 2005.

Maddrey WC.

J Clin Gastroenterol. 2005 Apr;39(4 Suppl 2):S83-9. Review.

PMID:
15758665
8.

Hepatotoxicity of antibacterials: Pathomechanisms and clinical.

Leitner JM, Graninger W, Thalhammer F.

Infection. 2010 Feb;38(1):3-11. doi: 10.1007/s15010-009-9179-z. Epub 2010 Jan 27. Review.

PMID:
20107858
9.

Hepatotoxicity with thiazolidinediones: is it a class effect?

Scheen AJ.

Drug Saf. 2001;24(12):873-88. Review.

PMID:
11735645
10.

Review article: drug-induced liver injury in clinical practice.

Björnsson E.

Aliment Pharmacol Ther. 2010 Jul;32(1):3-13. doi: 10.1111/j.1365-2036.2010.04320.x. Epub 2010 Mar 31. Review.

11.

Fluvastatin and hepatic reactions: a signal from spontaneous reporting in Italy.

Conforti A, Magro L, Moretti U, Scotto S, Motola D, Salvo F, Ros B, Leone R.

Drug Saf. 2006;29(12):1163-72.

PMID:
17147462
12.

Hepatotoxicity associated with statin use: analysis of the cases included in the Spanish Hepatotoxicity Registry.

Perdices EV, Medina-Cáliz I, Hernando S, Ortega A, Martín-Ocaña F, Navarro JM, Peláez G, Castiella A, Hallal H, Romero-Gómez M, González-Jiménez A, Robles-Díaz M, Lucena MI, Andrade RJ.

Rev Esp Enferm Dig. 2014 Apr;106(4):246-54.

13.

[Hepatotoxicity by antibiotics: update in 2008].

Robles M, Andrade RJ.

Rev Esp Quimioter. 2008 Dec;21(4):224-33. Review. Spanish.

14.

Second-generation thiazolidinediones and hepatotoxicity.

Marcy TR, Britton ML, Blevins SM.

Ann Pharmacother. 2004 Sep;38(9):1419-23. Epub 2004 Jul 20.

PMID:
15266041
15.

Hepatotoxicity of the thiazolidinediones.

Tolman KG, Chandramouli J.

Clin Liver Dis. 2003 May;7(2):369-79, vi. Review.

PMID:
12879989
16.

Jaundice due to suspected statin hepatotoxicity: a case series.

Bergmann OM, Kristjansson G, Jonasson JG, Björnsson ES.

Dig Dis Sci. 2012 Jul;57(7):1959-64. doi: 10.1007/s10620-011-1950-1. Epub 2011 Nov 11.

PMID:
22075853
17.

Mitochondrial impairment by PPAR agonists and statins identified via immunocaptured OXPHOS complex activities and respiration.

Nadanaciva S, Dykens JA, Bernal A, Capaldi RA, Will Y.

Toxicol Appl Pharmacol. 2007 Sep 15;223(3):277-87. Epub 2007 Jun 21.

PMID:
17658574
18.

Chronic liver injury induced by drugs: a systematic review.

Stine JG, Chalasani N.

Liver Int. 2015 Nov;35(11):2343-53. doi: 10.1111/liv.12958. Epub 2015 Sep 27. Review.

PMID:
26346512
19.

[Mechanisms of hepatotoxicity].

Bertolami MC.

Arq Bras Cardiol. 2005 Oct;85 Suppl 5:25-7. Epub 2006 Jan 2. Portuguese.

20.

Supplemental Content

Support Center